MENU
+Compare
BOLD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.96
Change
-$0.04 (-2.00%)
Capitalization
43.71M

BOLD Boundless Bio Forecast, Technical & Fundamental Analysis

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BOLD with price predictions
Feb 21, 2025

Momentum Indicator for BOLD turns negative, indicating new downward trend

BOLD saw its Momentum Indicator move below the 0 level on January 30, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator turned negative. In of the 11 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BOLD turned negative on February 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 6 similar instances when the indicator turned negative. In of the 6 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOLD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BOLD entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BOLD's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOLD advanced for three days, in of 43 cases, the price rose further within the following month. The odds of a continued upward trend are .

BOLD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.265) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). BOLD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BOLD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BOLD is expected to report earnings to rise 13.51% to -83 cents per share on February 26

Boundless Bio BOLD Stock Earnings Reports
Q4'24
Est.
$-0.84
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.12
The last earnings report on November 08 showed earnings per share of -74 cents, missing the estimate of -73 cents. With 329.07K shares outstanding, the current market capitalization sits at 43.71M.
A.I. Advisor
published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSDMX12.34-0.11
-0.88%
Morgan Stanley Emerging Mkt ex China R6
DEMZX22.39-0.20
-0.89%
Macquarie Emerging Markets R6
WBIGX27.62-0.28
-1.00%
William Blair International Growth N
CMJIX42.11-0.81
-1.89%
Calvert US Mid Cap Core Rspnb Idx I
ASCQX16.12-0.49
-2.95%
American Century Small Company I

BOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KOD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-2.00%
KOD - BOLD
43%
Loosely correlated
-6.12%
AKBA - BOLD
34%
Loosely correlated
-5.76%
ETXPF - BOLD
32%
Poorly correlated
N/A
TNXP - BOLD
26%
Poorly correlated
-5.17%
GRI - BOLD
25%
Poorly correlated
-4.64%
More